Table 1. Clinical features of SSc subjects undergoing skin biopsy for immunofluorescence analysis.
| Age (yrs) | Sex | MRSS | Skin score at biopsy site | Disease duration time of biopsy (months) | |
|---|---|---|---|---|---|
| SSc 1 | 49 | F | 3 | 0 | 44 |
| SSc 2 | 51 | M | 48 | 3 | 9 |
| SSc 3 | 50 | F | 24 | 2 | 101 |
| SSc 4 | 34 | F | 32 | 2 | 40 |
| SSc 5 | 57 | F | 11 | 1 | 64 |
| SSc 6 | 50 | F | 9 | 1 | 8 |
| SSc 7 | 58 | F | 3 | 0 | 45 |
| SSc 8 | 55 | F | 7 | 0 | 116 |
All skin biopsies were obtained from the forearm. MRSS, modified Rodnan Skin score (maximum 51). Biopsy site skin scores are as follows: 0, normal; 1, mild skin thickening; 2, moderate thickening; 3, severe thickening.